Recent research found that walking 5,000 steps three times a week for two years could add three years to a person’s life expectancy and decrease their healthcare costs by up to 13%.
All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt ...